Literature DB >> 775149

Eliminatory action of glycine on drug resistance of Escherichia coli K12 harboring an R factor.

M Tomoeda, M Inuzuka, M Hayashi.   

Abstract

Glycine, known to inhibit the synthesis of a peptidoglycan component of the bacterial cell wall, was effective in eliminating drug resistance of Escherichia coli K12 JE2100 strain harboring theR100-1 factor although in lower frequencies than that of sodium dodecyl sulfate (SDS). The action of glycine was found to be less effective on the same R factor in JE177 strain, and not effective on the F factor in W6. Infection of R factors from R+ cells to R- cells was found to take place in the glycine broth as efficiently as in broth without glycine. This might result in lowering the apparent efficiency of the action of glycine on those plasmids. The segregation patterns of drug-susceptible clones obtained by the glycine treatment were different from those obtained after the SDS treatment. These results coupled with other evidences suggest that the mode of action of glycine on R+ cells maybe different from those of other curing agents and may involve mechanisms other than selection of R- or drug susceptible segregantsthat are present in R+ culture.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 775149     DOI: 10.1111/j.1348-0421.1976.tb00904.x

Source DB:  PubMed          Journal:  Jpn J Microbiol        ISSN: 0021-5139


  2 in total

1.  In vitro susceptibility of Pseudomonas aeruginosa to carbenicillin, glycine, and ethylenediaminetetraacetic acid combinations.

Authors:  G F Gerberick; P A Castric
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

2.  Sub lethal levels of platinum nanoparticle cures plasmid and in combination with carbapenem, curtails carbapenem resistant Escherichia coli.

Authors:  Subhashree Bharathan; Niranjana Sri Sundaramoorthy; Harini Chandrasekaran; Gagana Rangappa; GaneshPrasad ArunKumar; Siva Bala Subramaniyan; Anbazhagan Veerappan; Saisubramanian Nagarajan
Journal:  Sci Rep       Date:  2019-03-28       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.